DEANDRA RANSOM: Open Payments
NPI 1679906168 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,397 in 108 payments from 17 companies in 2025. Trend: 2023 $2,107 · 2024 $1,765 · 2025 $2,397
Food & beverage: $2,316Education: $81
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 12 | $428 |
| Janssen Biotech, Inc. | 7 | $236 |
| Regeneron Healthcare Solutions, Inc. | 14 | $218 |
| Galderma Laboratories, L.P. | 18 | $210 |
| Lilly USA, LLC | 6 | $204 |
| ABBVIE INC. | 11 | $195 |
| Novartis Pharmaceuticals Corporation | 7 | $164 |
| PFIZER INC. | 8 | $149 |
| GENZYME CORPORATION | 5 | $123 |
| Organon LLC | 5 | $95 |
Products named: Bimzelx, DUPIXENT, TREMFYA, NEMLUVIO, CIBINQO, TALTZ, SKYRIZI, Rhapsido.
Industry payments across TX — which companies pay providers there.
